Human Papilloma Virus Testing - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509242480

Publication Date:

September 19, 2024

Pages:

149

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Human Papilloma Virus Testing is the procedure to test if the patient have the Human Papilloma Virus
The global market for Human Papilloma Virus Testing was estimated to be worth US$ 757 million in 2023 and is forecast to a readjusted size of US$ 1103.2 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030
North American market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Human Papilloma Virus Testing include Roche, AgilentTechnologies, Inc., Becton, DickinsonandCompany, QiagenN.V., ThermoFisherScientificInc., AbbottLaboratories, HologicInc., CepheidInc. and SeegenEInc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Papilloma Virus Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Papilloma Virus Testing by region & country, by Type, and by Application.
The Human Papilloma Virus Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papilloma Virus Testing.
麻豆原创 Segmentation
By Company
Roche
AgilentTechnologies, Inc.
Becton, DickinsonandCompany
QiagenN.V.
ThermoFisherScientificInc.
AbbottLaboratories
HologicInc.
CepheidInc.
SeegenEInc.
TakarABioInc.
DaAnGenECo., Ltd.of SunYat-SenUniversity
PromegACorporation
GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
EnzoBiochemInc.
NorgenBiotek Corp.
DiagCorBiosciencEIncLtd
HybribioLimited
ZytovisionGmbH
ArborVitACorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics, Inc.
Segment by Type:
Pap Smear Test
HPV DNA Test
Segment by Application
Diagnostic Centers
Hospitals
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Papilloma Virus Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Human Papilloma Virus Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Human Papilloma Virus Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Human Papilloma Virus Testing Product Introduction
1.2 Global Human Papilloma Virus Testing 麻豆原创 Size Forecast
1.3 Human Papilloma Virus Testing 麻豆原创 Trends & Drivers
1.3.1 Human Papilloma Virus Testing Industry Trends
1.3.2 Human Papilloma Virus Testing 麻豆原创 Drivers & Opportunity
1.3.3 Human Papilloma Virus Testing 麻豆原创 Challenges
1.3.4 Human Papilloma Virus Testing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Papilloma Virus Testing Players Revenue Ranking (2023)
2.2 Global Human Papilloma Virus Testing Revenue by Company (2019-2024)
2.3 Key Companies Human Papilloma Virus Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Papilloma Virus Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Papilloma Virus Testing
2.6 Human Papilloma Virus Testing 麻豆原创 Competitive Analysis
2.6.1 Human Papilloma Virus Testing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Papilloma Virus Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papilloma Virus Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pap Smear Test
3.1.2 HPV DNA Test
3.2 Global Human Papilloma Virus Testing Sales Value by Type
3.2.1 Global Human Papilloma Virus Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Papilloma Virus Testing Sales Value, by Type (2019-2030)
3.2.3 Global Human Papilloma Virus Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Centers
4.1.2 Hospitals
4.1.3 Clinic
4.2 Global Human Papilloma Virus Testing Sales Value by Application
4.2.1 Global Human Papilloma Virus Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Papilloma Virus Testing Sales Value, by Application (2019-2030)
4.2.3 Global Human Papilloma Virus Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Papilloma Virus Testing Sales Value by Region
5.1.1 Global Human Papilloma Virus Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Papilloma Virus Testing Sales Value by Region (2019-2024)
5.1.3 Global Human Papilloma Virus Testing Sales Value by Region (2025-2030)
5.1.4 Global Human Papilloma Virus Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Papilloma Virus Testing Sales Value, 2019-2030
5.2.2 North America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Papilloma Virus Testing Sales Value, 2019-2030
5.3.2 Europe Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Papilloma Virus Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Papilloma Virus Testing Sales Value, 2019-2030
5.5.2 South America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Papilloma Virus Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Papilloma Virus Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Papilloma Virus Testing Sales Value
6.3 United States
6.3.1 United States Human Papilloma Virus Testing Sales Value, 2019-2030
6.3.2 United States Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Papilloma Virus Testing Sales Value, 2019-2030
6.4.2 Europe Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Papilloma Virus Testing Sales Value, 2019-2030
6.5.2 China Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Papilloma Virus Testing Sales Value, 2019-2030
6.6.2 Japan Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Papilloma Virus Testing Sales Value, 2019-2030
6.7.2 South Korea Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Papilloma Virus Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Papilloma Virus Testing Sales Value, 2019-2030
6.9.2 India Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Human Papilloma Virus Testing Products, Services and Solutions
7.1.4 Roche Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 AgilentTechnologies, Inc.
7.2.1 AgilentTechnologies, Inc. Profile
7.2.2 AgilentTechnologies, Inc. Main Business
7.2.3 AgilentTechnologies, Inc. Human Papilloma Virus Testing Products, Services and Solutions
7.2.4 AgilentTechnologies, Inc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.2.5 AgilentTechnologies, Inc. Recent Developments
7.3 Becton, DickinsonandCompany
7.3.1 Becton, DickinsonandCompany Profile
7.3.2 Becton, DickinsonandCompany Main Business
7.3.3 Becton, DickinsonandCompany Human Papilloma Virus Testing Products, Services and Solutions
7.3.4 Becton, DickinsonandCompany Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.3.5 QiagenN.V. Recent Developments
7.4 QiagenN.V.
7.4.1 QiagenN.V. Profile
7.4.2 QiagenN.V. Main Business
7.4.3 QiagenN.V. Human Papilloma Virus Testing Products, Services and Solutions
7.4.4 QiagenN.V. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.4.5 QiagenN.V. Recent Developments
7.5 ThermoFisherScientificInc.
7.5.1 ThermoFisherScientificInc. Profile
7.5.2 ThermoFisherScientificInc. Main Business
7.5.3 ThermoFisherScientificInc. Human Papilloma Virus Testing Products, Services and Solutions
7.5.4 ThermoFisherScientificInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.5.5 ThermoFisherScientificInc. Recent Developments
7.6 AbbottLaboratories
7.6.1 AbbottLaboratories Profile
7.6.2 AbbottLaboratories Main Business
7.6.3 AbbottLaboratories Human Papilloma Virus Testing Products, Services and Solutions
7.6.4 AbbottLaboratories Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.6.5 AbbottLaboratories Recent Developments
7.7 HologicInc.
7.7.1 HologicInc. Profile
7.7.2 HologicInc. Main Business
7.7.3 HologicInc. Human Papilloma Virus Testing Products, Services and Solutions
7.7.4 HologicInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.7.5 HologicInc. Recent Developments
7.8 CepheidInc.
7.8.1 CepheidInc. Profile
7.8.2 CepheidInc. Main Business
7.8.3 CepheidInc. Human Papilloma Virus Testing Products, Services and Solutions
7.8.4 CepheidInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.8.5 CepheidInc. Recent Developments
7.9 SeegenEInc.
7.9.1 SeegenEInc. Profile
7.9.2 SeegenEInc. Main Business
7.9.3 SeegenEInc. Human Papilloma Virus Testing Products, Services and Solutions
7.9.4 SeegenEInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.9.5 SeegenEInc. Recent Developments
7.10 TakarABioInc.
7.10.1 TakarABioInc. Profile
7.10.2 TakarABioInc. Main Business
7.10.3 TakarABioInc. Human Papilloma Virus Testing Products, Services and Solutions
7.10.4 TakarABioInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.10.5 TakarABioInc. Recent Developments
7.11 DaAnGenECo., Ltd.of SunYat-SenUniversity
7.11.1 DaAnGenECo., Ltd.of SunYat-SenUniversity Profile
7.11.2 DaAnGenECo., Ltd.of SunYat-SenUniversity Main Business
7.11.3 DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Products, Services and Solutions
7.11.4 DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.11.5 DaAnGenECo., Ltd.of SunYat-SenUniversity Recent Developments
7.12 PromegACorporation
7.12.1 PromegACorporation Profile
7.12.2 PromegACorporation Main Business
7.12.3 PromegACorporation Human Papilloma Virus Testing Products, Services and Solutions
7.12.4 PromegACorporation Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.12.5 PromegACorporation Recent Developments
7.13 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
7.13.1 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Profile
7.13.2 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Main Business
7.13.3 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Products, Services and Solutions
7.13.4 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.13.5 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Recent Developments
7.14 EnzoBiochemInc.
7.14.1 EnzoBiochemInc. Profile
7.14.2 EnzoBiochemInc. Main Business
7.14.3 EnzoBiochemInc. Human Papilloma Virus Testing Products, Services and Solutions
7.14.4 EnzoBiochemInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.14.5 EnzoBiochemInc. Recent Developments
7.15 NorgenBiotek Corp.
7.15.1 NorgenBiotek Corp. Profile
7.15.2 NorgenBiotek Corp. Main Business
7.15.3 NorgenBiotek Corp. Human Papilloma Virus Testing Products, Services and Solutions
7.15.4 NorgenBiotek Corp. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.15.5 NorgenBiotek Corp. Recent Developments
7.16 DiagCorBiosciencEIncLtd
7.16.1 DiagCorBiosciencEIncLtd Profile
7.16.2 DiagCorBiosciencEIncLtd Main Business
7.16.3 DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Products, Services and Solutions
7.16.4 DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.16.5 DiagCorBiosciencEIncLtd Recent Developments
7.17 HybribioLimited
7.17.1 HybribioLimited Profile
7.17.2 HybribioLimited Main Business
7.17.3 HybribioLimited Human Papilloma Virus Testing Products, Services and Solutions
7.17.4 HybribioLimited Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.17.5 HybribioLimited Recent Developments
7.18 ZytovisionGmbH
7.18.1 ZytovisionGmbH Profile
7.18.2 ZytovisionGmbH Main Business
7.18.3 ZytovisionGmbH Human Papilloma Virus Testing Products, Services and Solutions
7.18.4 ZytovisionGmbH Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.18.5 ZytovisionGmbH Recent Developments
7.19 ArborVitACorporation
7.19.1 ArborVitACorporation Profile
7.19.2 ArborVitACorporation Main Business
7.19.3 ArborVitACorporation Human Papilloma Virus Testing Products, Services and Solutions
7.19.4 ArborVitACorporation Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.19.5 ArborVitACorporation Recent Developments
7.20 Medical& BiologicalLaboratoriesCo., Ltd
7.20.1 Medical& BiologicalLaboratoriesCo., Ltd Profile
7.20.2 Medical& BiologicalLaboratoriesCo., Ltd Main Business
7.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Products, Services and Solutions
7.20.4 Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Developments
7.21 Fujirebio Diagnostics, Inc.
7.21.1 Fujirebio Diagnostics, Inc. Profile
7.21.2 Fujirebio Diagnostics, Inc. Main Business
7.21.3 Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Products, Services and Solutions
7.21.4 Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.21.5 Fujirebio Diagnostics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Human Papilloma Virus Testing Industrial Chain
8.2 Human Papilloma Virus Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Papilloma Virus Testing Sales Model
8.5.2 Sales Channel
8.5.3 Human Papilloma Virus Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Roche
AgilentTechnologies, Inc.
Becton, DickinsonandCompany
QiagenN.V.
ThermoFisherScientificInc.
AbbottLaboratories
HologicInc.
CepheidInc.
SeegenEInc.
TakarABioInc.
DaAnGenECo., Ltd.of SunYat-SenUniversity
PromegACorporation
GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
EnzoBiochemInc.
NorgenBiotek Corp.
DiagCorBiosciencEIncLtd
HybribioLimited
ZytovisionGmbH
ArborVitACorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.